Abstract
Almost 100% glioblastoma (GBM) recurs following extensive therapies. Current strategies of treatment of recurrent GBM varies from center to center and it depends on the site, size, and vascularity of the recurrent tumors. In this chapter, current views of managing recurrent GBM is discussed and also possible alternative intervention is pointed out.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: New Targeting in the Reversal of Resistant Glioblastomas
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.